MYC and cancer: Venetoclax was chosen here for its translational potential, as it was recently granted accelerated approval by the FDA for a cancer indication40 and it also synergized with metformin to induce MYC-dependent apoptosis (Fig. 5a, Supplementary Figure 4A).